September 17-19, 2023 | Washington, DC

The Parenteral Drug Association (PDA) and the U.S. Food and Drug Administration (FDA) are once again co-sponsoring the PDA/FDA Joint Regulatory Conference, which is now in its 32nd year. This flagship conference provides opportunities for attendees to learn about current issues relating to manufacturing and quality assurance. This year’s theme is CGMP: Quality Through Science and Innovation. 

The Conference emphasizes the role of effective quality systems in ensuring an ongoing state of control throughout the product lifecycle by vigilantly managing risks to manufacturing and quality. The roles of robust systems, facilities, processes, raw material quality, supplier relationships, industrial modernization, and quality risk management are emphasized. Case studies are presented throughout the conference to provide practical insights into these concepts and illustrate how sustainable compliance establishes the foundation for quality and supply consistency. International collaboration efforts that improve quality and benefit the consumer are also highlighted. 

On Day 2 of the conference, HG’s very own CEO Kir Henrici will be presenting during session A4: Data Integrity: A Key to Innovation. Her presentation is entitled “Data Integrity, Journey from Compliance to Competitive Advantage.” We look forward to the conference and her presentation and hope to see you there!

Click here to learn more!